Skip to content
Search

Latest Stories

Lateral flow testing in community pharmacy

Community pharmacies in several parts of England are now providing lateral flow testing (LFT) as part of a local authority organised service.

This includes pharmacies in parts of London, including Kingston and Merton, where they are providing testing programmes for asymptomatic residents.


Lateral flow testing is a fast and simple way to test people who do not have symptoms of Covid-19, but who may still be spreading the virus.

The tests are easy to use and give results in 30 minutes.

Around one in three people with Covid-19 do not have symptoms, so a test that rapidly detects these otherwise hidden cases is a very useful additional tool for tackling the virus.

Commenting on the services they have helped implement, Amit Patel, chief officer, Merton, Sutton and Wandsworth LPC, said: “The LFT service has been a huge support to keyworkers across Merton, where we have a number of pharmacies delivering up to 150 tests each per week, enabling them to go to work and support the community.

"Our public health team have been hugely supportive and have worked hard with the LPC to ensure that we maximise on this opportunity. We have been told by them on numerous occasions that the role pharmacy has played through the pandemic has really helped them as commissioners see us as a real and viable solution to local issues.

“The service was up and running within a week and includes an enhanced service where the pharmacy team can take the opportunity to give additional advice on issues such as hands, face space, smoking and obesity which are proven to exacerbate Covid-19 symptoms. It is a great service to show how our healthy living pharmacies can work as a team with the oversight of the pharmacist.“

Lateral flow is an established technology, adapted to detect proteins (antigens) that are present when a person has Covid-19.

Lateral flow antigen testing involves processing a throat and nasal swab sample with an extraction fluid and a lateral flow device. Most of the lateral flow testing in England is currently conducted at asymptomatic test sites, which are implemented in a range of community settings such as pharmacies, universities, schools, care homes and workplaces.

Michael Keen, chief officer of Kingston, Richmond and Twickenham LPC, added: “In Kingston, Richmond and South West London, our LPCs work closely with the Boroughs and have good working relationships with the Directors of Public Health.

"This service is a result of those relationships. It is important to community pharmacy because it addresses a public need, helps to build on the trust members of the public have in us to tackle Covid-19 related health matters, and helps people manage a pandemic that has them very worried.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less